AstraZeneca signs strategic partnership with Beijing; invests $2.5bn FinanceAsia Economics
AstraZeneca invests $2.5bn to build new R&D centre in Beijing, China World Pharmaceutical Frontiers Economics
AstraZeneca plans £2bn investment in Beijing despite ongoing China investigation Share Talk Economics
AstraZeneca to invest $2.5bn in drugs research and manfacturing in Beijing The Guardian Economics
AstraZeneca to invest £2bn in China amid Beijing police investigation Yahoo Finance Economics
AstraZeneca to invest £2bn in Beijing amid China investigation The Telegraph Economics
AstraZeneca to invest $2.5 billion in Beijing hub as it looks beyond Chinese tax probe NBC Chicago Economics
AstraZeneca announces landmark US$2.5 billion investment in Beijing's biopharmaceutical sector Dimsum Daily Economics
AstraZeneca expands in China with a $2.5B investment in Beijing MSN Economics
AstraZeneca to invest $2.5B in Beijing R&D and manufacturing TipRanks Economics
AstraZeneca to invest $2.5 billion in Beijing hub as it seeks to move on from China probes NBC Philadelphia Economics
AstraZeneca Invests $2.5 Billion in Beijing, Undeterred by Probe Yahoo Finance Economics